| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 33 | 2025 | 540 | 10.180 |
Why?
|
| Hematopoiesis | 18 | 2025 | 216 | 5.820 |
Why?
|
| Hematologic Diseases | 5 | 2024 | 79 | 3.070 |
Why?
|
| Interferon-gamma | 6 | 2024 | 506 | 2.030 |
Why?
|
| Cell Differentiation | 12 | 2025 | 1896 | 1.690 |
Why?
|
| Bone Marrow | 7 | 2022 | 325 | 1.450 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 138 | 1.450 |
Why?
|
| Antigens, CD | 2 | 2024 | 432 | 1.410 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2024 | 702 | 1.330 |
Why?
|
| Interferon Type I | 2 | 2022 | 107 | 1.200 |
Why?
|
| Inflammation | 7 | 2024 | 1445 | 1.120 |
Why?
|
| Interferon-alpha | 4 | 2018 | 230 | 1.070 |
Why?
|
| GPI-Linked Proteins | 2 | 2024 | 101 | 1.060 |
Why?
|
| Bone Marrow Cells | 5 | 2021 | 264 | 1.030 |
Why?
|
| Mice | 31 | 2025 | 17634 | 0.970 |
Why?
|
| Animals | 40 | 2025 | 34220 | 0.950 |
Why?
|
| Bone Marrow Diseases | 2 | 2022 | 41 | 0.920 |
Why?
|
| Clonal Evolution | 2 | 2025 | 40 | 0.890 |
Why?
|
| Cell Proliferation | 8 | 2018 | 2312 | 0.880 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2023 | 8 | 0.850 |
Why?
|
| Anemia | 2 | 2017 | 340 | 0.830 |
Why?
|
| Mice, Knockout | 7 | 2024 | 3745 | 0.830 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 314 | 0.810 |
Why?
|
| Signal Transduction | 13 | 2023 | 4534 | 0.810 |
Why?
|
| Anti-Bacterial Agents | 7 | 2021 | 2426 | 0.810 |
Why?
|
| Epigenesis, Genetic | 5 | 2025 | 676 | 0.810 |
Why?
|
| Thrombocythemia, Essential | 3 | 2021 | 30 | 0.800 |
Why?
|
| Interferons | 2 | 2021 | 125 | 0.760 |
Why?
|
| Immunomodulation | 1 | 2022 | 79 | 0.750 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2020 | 11 | 0.710 |
Why?
|
| Stem Cells | 2 | 2024 | 706 | 0.700 |
Why?
|
| Streptococcal Infections | 3 | 2022 | 240 | 0.700 |
Why?
|
| Busulfan | 1 | 2020 | 45 | 0.700 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2020 | 30 | 0.690 |
Why?
|
| Mice, Inbred C57BL | 14 | 2025 | 4405 | 0.680 |
Why?
|
| GTP-Binding Proteins | 2 | 2011 | 179 | 0.680 |
Why?
|
| Immunologic Factors | 1 | 2021 | 174 | 0.650 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 218 | 0.620 |
Why?
|
| Polycythemia Vera | 2 | 2018 | 39 | 0.620 |
Why?
|
| STAT1 Transcription Factor | 2 | 2016 | 73 | 0.610 |
Why?
|
| Hydroxyurea | 2 | 2018 | 82 | 0.600 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2025 | 27 | 0.600 |
Why?
|
| Dysbiosis | 2 | 2024 | 122 | 0.600 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 411 | 0.600 |
Why?
|
| Neoplasms | 2 | 2023 | 2792 | 0.590 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2024 | 1201 | 0.580 |
Why?
|
| Bromodeoxyuridine | 1 | 2018 | 61 | 0.580 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2017 | 9 | 0.570 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2017 | 12 | 0.570 |
Why?
|
| Erythroid Precursor Cells | 1 | 2017 | 24 | 0.570 |
Why?
|
| Abscess | 1 | 2019 | 137 | 0.570 |
Why?
|
| Histamine | 1 | 2017 | 45 | 0.570 |
Why?
|
| Environmental Exposure | 1 | 2019 | 220 | 0.560 |
Why?
|
| Flow Cytometry | 2 | 2018 | 794 | 0.560 |
Why?
|
| Erythropoiesis | 1 | 2017 | 39 | 0.560 |
Why?
|
| Sepsis | 1 | 2022 | 481 | 0.560 |
Why?
|
| Microbiota | 1 | 2022 | 389 | 0.540 |
Why?
|
| Thrombocytosis | 1 | 2016 | 34 | 0.530 |
Why?
|
| Leukopenia | 1 | 2016 | 45 | 0.520 |
Why?
|
| Cytokines | 7 | 2022 | 1288 | 0.520 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 833 | 0.510 |
Why?
|
| Osteomyelitis | 1 | 2019 | 207 | 0.510 |
Why?
|
| MicroRNAs | 2 | 2025 | 835 | 0.500 |
Why?
|
| Stress, Physiological | 1 | 2017 | 254 | 0.490 |
Why?
|
| Mutation | 9 | 2025 | 5849 | 0.490 |
Why?
|
| Cat-Scratch Disease | 1 | 2015 | 33 | 0.470 |
Why?
|
| Disease Management | 1 | 2019 | 527 | 0.470 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 97 | 0.470 |
Why?
|
| Clone Cells | 3 | 2025 | 167 | 0.450 |
Why?
|
| Humans | 38 | 2025 | 125090 | 0.440 |
Why?
|
| Epithelium | 1 | 2015 | 363 | 0.440 |
Why?
|
| Candidiasis | 2 | 2019 | 129 | 0.440 |
Why?
|
| Virus Diseases | 1 | 2015 | 280 | 0.380 |
Why?
|
| Graft vs Host Disease | 3 | 2024 | 542 | 0.380 |
Why?
|
| Receptors, Interferon | 1 | 2011 | 25 | 0.370 |
Why?
|
| Alchemy | 1 | 2011 | 3 | 0.360 |
Why?
|
| Cell Lineage | 4 | 2020 | 345 | 0.360 |
Why?
|
| Dermis | 1 | 2011 | 24 | 0.360 |
Why?
|
| Science | 1 | 2011 | 33 | 0.350 |
Why?
|
| Immunity | 1 | 2011 | 192 | 0.340 |
Why?
|
| Epithelial Cells | 1 | 2015 | 909 | 0.340 |
Why?
|
| Homeostasis | 4 | 2018 | 703 | 0.330 |
Why?
|
| Leprostatic Agents | 1 | 2009 | 2 | 0.320 |
Why?
|
| Leprosy | 1 | 2009 | 19 | 0.320 |
Why?
|
| Lipopeptides | 1 | 2009 | 33 | 0.320 |
Why?
|
| Adoption | 1 | 2009 | 16 | 0.320 |
Why?
|
| Fungemia | 1 | 2009 | 22 | 0.320 |
Why?
|
| Cell Cycle | 4 | 2018 | 618 | 0.310 |
Why?
|
| Echinocandins | 1 | 2009 | 44 | 0.310 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2009 | 136 | 0.300 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2009 | 107 | 0.290 |
Why?
|
| Tuberculosis | 2 | 2011 | 525 | 0.290 |
Why?
|
| Cell Division | 2 | 2020 | 781 | 0.280 |
Why?
|
| Streptococcus pyogenes | 3 | 2005 | 76 | 0.280 |
Why?
|
| Macrophages | 2 | 2024 | 624 | 0.280 |
Why?
|
| Hematologic Neoplasms | 2 | 2021 | 286 | 0.270 |
Why?
|
| Infant, Premature, Diseases | 1 | 2009 | 244 | 0.260 |
Why?
|
| Antifungal Agents | 1 | 2009 | 289 | 0.260 |
Why?
|
| Fibroblasts | 1 | 2011 | 878 | 0.260 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 4393 | 0.260 |
Why?
|
| Myeloid Cells | 2 | 2017 | 102 | 0.250 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 539 | 0.240 |
Why?
|
| Janus Kinase 2 | 2 | 2018 | 132 | 0.240 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2025 | 34 | 0.240 |
Why?
|
| Bone Marrow Stromal Antigen 2 | 1 | 2024 | 5 | 0.230 |
Why?
|
| Glutathione Peroxidase | 2 | 2004 | 53 | 0.230 |
Why?
|
| Bacteroides | 1 | 2024 | 34 | 0.230 |
Why?
|
| Membrane Microdomains | 1 | 2024 | 61 | 0.220 |
Why?
|
| Pulmonary Fibrosis | 1 | 2025 | 109 | 0.220 |
Why?
|
| Interleukin-1alpha | 1 | 2023 | 8 | 0.210 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2023 | 28 | 0.210 |
Why?
|
| Cigarette Smoking | 1 | 2023 | 59 | 0.200 |
Why?
|
| Female | 13 | 2025 | 66748 | 0.200 |
Why?
|
| Cell Self Renewal | 2 | 2025 | 43 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2634 | 0.190 |
Why?
|
| Peroxidases | 2 | 2005 | 26 | 0.190 |
Why?
|
| Streptococcus | 1 | 2022 | 60 | 0.190 |
Why?
|
| Mice, SCID | 1 | 2022 | 569 | 0.190 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 1711 | 0.190 |
Why?
|
| Sarcoma, Myeloid | 1 | 2021 | 12 | 0.180 |
Why?
|
| Leukemia, B-Cell | 1 | 2021 | 26 | 0.180 |
Why?
|
| Gene Expression | 3 | 2016 | 1561 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2024 | 372 | 0.180 |
Why?
|
| E-Selectin | 1 | 2020 | 42 | 0.180 |
Why?
|
| Radiation Chimera | 1 | 2020 | 15 | 0.180 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 36 | 0.180 |
Why?
|
| Interleukin-6 | 1 | 2022 | 420 | 0.180 |
Why?
|
| Inhalation Exposure | 1 | 2020 | 36 | 0.180 |
Why?
|
| Male | 11 | 2025 | 61470 | 0.170 |
Why?
|
| Intestines | 1 | 2024 | 577 | 0.170 |
Why?
|
| Fluorouracil | 1 | 2020 | 128 | 0.170 |
Why?
|
| Smoke | 1 | 2020 | 60 | 0.170 |
Why?
|
| Tobacco Products | 1 | 2020 | 61 | 0.170 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1694 | 0.170 |
Why?
|
| Hydrogen Peroxide | 1 | 2000 | 112 | 0.170 |
Why?
|
| Stem Cell Transplantation | 1 | 2022 | 238 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 3156 | 0.170 |
Why?
|
| Toll-Like Receptors | 2 | 2018 | 84 | 0.170 |
Why?
|
| Repressor Proteins | 2 | 2005 | 813 | 0.170 |
Why?
|
| Thyroid Crisis | 1 | 2019 | 5 | 0.160 |
Why?
|
| Thyroiditis, Suppurative | 1 | 2019 | 5 | 0.160 |
Why?
|
| Protein Phosphatase 2C | 1 | 2019 | 54 | 0.160 |
Why?
|
| Candida tropicalis | 1 | 2019 | 16 | 0.160 |
Why?
|
| Bacterial Proteins | 2 | 2005 | 888 | 0.160 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 558 | 0.160 |
Why?
|
| Mycobacterium avium | 2 | 2016 | 16 | 0.160 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2018 | 2 | 0.150 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 149 | 0.150 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 52 | 0.150 |
Why?
|
| Models, Immunological | 1 | 2018 | 36 | 0.150 |
Why?
|
| Nutrition Disorders | 1 | 2018 | 32 | 0.150 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 618 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2023 | 519 | 0.140 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 85 | 0.140 |
Why?
|
| Granulocytes | 1 | 2016 | 65 | 0.130 |
Why?
|
| Germ-Free Life | 1 | 2016 | 60 | 0.130 |
Why?
|
| Neutropenia | 1 | 2018 | 200 | 0.130 |
Why?
|
| DNA Damage | 1 | 2019 | 513 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 228 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 139 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 546 | 0.130 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2016 | 98 | 0.130 |
Why?
|
| Apoptosis | 1 | 2022 | 1806 | 0.130 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 293 | 0.130 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 20 | 0.130 |
Why?
|
| Graft Survival | 1 | 2018 | 535 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 57 | 0.130 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 39 | 0.120 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 59 | 0.120 |
Why?
|
| Zinc Fingers | 1 | 2016 | 119 | 0.120 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2015 | 16 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 140 | 0.120 |
Why?
|
| Methanococcus | 1 | 1995 | 2 | 0.120 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2396 | 0.120 |
Why?
|
| Societies, Scientific | 1 | 2014 | 26 | 0.120 |
Why?
|
| Immunophenotyping | 2 | 2016 | 330 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 49 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2005 | 2588 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 55 | 0.110 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2014 | 16 | 0.110 |
Why?
|
| Hematology | 1 | 2014 | 38 | 0.110 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2014 | 31 | 0.110 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 211 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 397 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2015 | 340 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 304 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 534 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2016 | 525 | 0.110 |
Why?
|
| Protein Kinases | 1 | 1995 | 330 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 209 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 783 | 0.100 |
Why?
|
| Antiviral Agents | 1 | 2018 | 752 | 0.100 |
Why?
|
| Organoids | 2 | 2025 | 281 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 429 | 0.090 |
Why?
|
| Receptors, Cytokine | 1 | 2011 | 68 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 2 | 2011 | 575 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 2047 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 69 | 0.090 |
Why?
|
| Texas | 1 | 2019 | 3587 | 0.090 |
Why?
|
| Aging | 3 | 2025 | 1185 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 282 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 281 | 0.080 |
Why?
|
| Multipotent Stem Cells | 2 | 2025 | 27 | 0.080 |
Why?
|
| Infant | 2 | 2019 | 12477 | 0.080 |
Why?
|
| Ethiopia | 1 | 2009 | 21 | 0.080 |
Why?
|
| Liver Function Tests | 1 | 2009 | 101 | 0.080 |
Why?
|
| Aspartate Aminotransferases | 1 | 2009 | 82 | 0.080 |
Why?
|
| Genetic Markers | 1 | 2011 | 603 | 0.080 |
Why?
|
| Amphotericin B | 1 | 2009 | 90 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2011 | 735 | 0.080 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 157 | 0.080 |
Why?
|
| Prednisone | 1 | 2009 | 276 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1290 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 392 | 0.070 |
Why?
|
| Risk Factors | 1 | 2022 | 10284 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1016 | 0.070 |
Why?
|
| Regeneration | 2 | 2024 | 212 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 946 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2011 | 282 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1696 | 0.070 |
Why?
|
| Cholestasis | 1 | 2009 | 153 | 0.070 |
Why?
|
| Child | 3 | 2019 | 24391 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2005 | 3890 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 294 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2019 | 12388 | 0.070 |
Why?
|
| Adult | 2 | 2024 | 29627 | 0.060 |
Why?
|
| Alleles | 1 | 2011 | 1615 | 0.060 |
Why?
|
| Aged | 3 | 2022 | 19858 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 1169 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1697 | 0.060 |
Why?
|
| Peroxides | 1 | 2005 | 13 | 0.060 |
Why?
|
| Regulon | 1 | 2005 | 11 | 0.060 |
Why?
|
| Peroxiredoxins | 2 | 2005 | 9 | 0.060 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2025 | 62 | 0.060 |
Why?
|
| Time Factors | 1 | 2015 | 6328 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 2715 | 0.060 |
Why?
|
| Acetylation | 1 | 2025 | 164 | 0.060 |
Why?
|
| Bacteroides thetaiotaomicron | 1 | 2024 | 8 | 0.060 |
Why?
|
| Phylogeny | 2 | 2025 | 696 | 0.060 |
Why?
|
| Glycolysis | 1 | 2024 | 150 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2025 | 196 | 0.050 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2023 | 23 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2005 | 157 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2024 | 123 | 0.050 |
Why?
|
| Achievement | 1 | 2023 | 31 | 0.050 |
Why?
|
| Longevity | 1 | 2025 | 136 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2024 | 172 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2019 | 14007 | 0.050 |
Why?
|
| Research Personnel | 1 | 2023 | 117 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 280 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2024 | 998 | 0.050 |
Why?
|
| DNA Modification Methylases | 1 | 2022 | 44 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 292 | 0.050 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 364 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 193 | 0.050 |
Why?
|
| Histones | 1 | 2025 | 524 | 0.050 |
Why?
|
| Adolescent | 2 | 2019 | 19353 | 0.050 |
Why?
|
| Middle Aged | 2 | 2024 | 26918 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2000 | 13 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2019 | 16328 | 0.040 |
Why?
|
| Paraquat | 1 | 2000 | 13 | 0.040 |
Why?
|
| Feces | 1 | 2024 | 727 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 194 | 0.040 |
Why?
|
| Myeloproliferative Disorders | 1 | 2021 | 87 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2000 | 186 | 0.040 |
Why?
|
| Pulmonary Emphysema | 1 | 2020 | 93 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 346 | 0.040 |
Why?
|
| Ethanol | 1 | 2000 | 163 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2019 | 46 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 124 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2019 | 101 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2021 | 334 | 0.040 |
Why?
|
| Prognosis | 2 | 2018 | 4637 | 0.040 |
Why?
|
| Phenotype | 2 | 2012 | 4263 | 0.030 |
Why?
|
| Lung | 1 | 2025 | 1498 | 0.030 |
Why?
|
| Conserved Sequence | 2 | 1995 | 291 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 359 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2022 | 1020 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 683 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 472 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 1995 | 621 | 0.030 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 2 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 1064 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 2521 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2016 | 12 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2009 | 8205 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 236 | 0.030 |
Why?
|
| Eukaryotic Cells | 1 | 1995 | 32 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 243 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 381 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 73 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1995 | 211 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1398 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 253 | 0.030 |
Why?
|
| Immune System | 1 | 2014 | 89 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 724 | 0.030 |
Why?
|
| Multigene Family | 1 | 1995 | 299 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2016 | 267 | 0.030 |
Why?
|
| Virulence | 2 | 2005 | 263 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 166 | 0.030 |
Why?
|
| Genomics | 1 | 2021 | 1501 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2014 | 302 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 293 | 0.020 |
Why?
|
| Leukemia | 1 | 2014 | 371 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 523 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 881 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1005 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 254 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2562 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 3054 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 3080 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 1195 | 0.020 |
Why?
|
| DNA Footprinting | 1 | 2005 | 14 | 0.010 |
Why?
|
| Oxidants | 1 | 2005 | 31 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 478 | 0.010 |
Why?
|
| Zebrafish | 1 | 2004 | 379 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1329 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 518 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1757 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 3102 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 835 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 2905 | 0.010 |
Why?
|
| Glucokinase | 1 | 1995 | 16 | 0.010 |
Why?
|
| Glycerol Kinase | 1 | 1995 | 19 | 0.010 |
Why?
|
| Genes, Helminth | 1 | 1995 | 22 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1995 | 34 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 658 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 1995 | 223 | 0.010 |
Why?
|
| Software | 1 | 1995 | 683 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1995 | 1179 | 0.010 |
Why?
|